---
backup_url: ''
content_type: external-resource
external_url: http://www.forbes.com/sites/matthewherper/2013/10/31/array-biopharma-outlines-path-to-market-for-new-myeloma-drug/
has_external_licence_warning: true
has_external_license_warning: true
is_broken: ''
license: https://creativecommons.org/licenses/by-nc-sa/4.0/
title: Array Biopharma Outlines Path To Market For New Myeloma Drug
uid: efc8f125-1f14-473e-a941-87b82bd92148
---
